Associated equity: EMIS Group
EMIS is a clinical software supplier to the primary, community and acute care markets in the UK and provides software to the community pharmacy market. Its Patient business provides medical and wellbeing information as well as transactional services to patients.
EMIS Group — 11 videos in collection
EMIS Group is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a leading position with a market share of 57% of UK GP practices. It has expanded from this position to create a broad range of products serving the community healthcare market, the acute sector and community pharmacies (where it has c 37% share). Its Patient business provides medical and wellbeing information as well as transactional services to patients. The company strategy is to provide connected healthcare solutions to facilitate patient-centric care.
In this audio interview, CEO Andy Thorburn reviews the group’s financial and operational highlights for H120 and gives an overview of performance on a divisional basis. He talks about the impact of COVID-19 on the business so far this year and how he expects it to influence the business in H2. Discussing product development, he confirms continued development of the EMIS-X platform as well as the introduction of specific solutions to help the fight against COVID-19. With a strong cash position at the end of H1, Andy explains the company is well positioned to navigate through the current uncertainty and suggests the potential for M&A. Finally, he discusses the current trading environment and gives his views on the company’s short- and medium-term outlook.